These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25154787)

  • 1. Hepatic syndecan-1 changes associate with dyslipidemia after renal transplantation.
    Adepu S; Katta K; Tietge UJ; Kwakernaak AJ; Dam W; van Goor H; Dullaart RP; Navis GJ; Bakker SJ; van den Born J
    Am J Transplant; 2014 Oct; 14(10):2328-38. PubMed ID: 25154787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia in Progressive Renal Failure Is Associated with Changes in Hepatic Heparan Sulfate - PCSK9 Interaction.
    Shrestha P; Adepu S; Vivès RR; Masri RE; Klooster A; Kaptein F; Dam W; Bakker SJL; van Goor H; van de Sluis B; van den Born J
    J Am Soc Nephrol; 2021 Jun; 32(6):1371-1388. PubMed ID: 33758009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
    Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD
    J Clin Invest; 2009 Nov; 119(11):3236-45. PubMed ID: 19805913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incipient renal transplant dysfunction associates with tubular syndecan-1 expression and shedding.
    Adepu S; Rosman CW; Dam W; van Dijk MC; Navis G; van Goor H; Bakker SJ; van den Born J
    Am J Physiol Renal Physiol; 2015 Jul; 309(2):F137-45. PubMed ID: 25972509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.
    Deng Y; Foley EM; Gonzales JC; Gordts PL; Li Y; Esko JD
    Hepatology; 2012 Jan; 55(1):277-86. PubMed ID: 21898481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1.
    Chen K; Wu Q; Hu K; Yang C; Wu X; Cheung P; Williams KJ
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):102-113. PubMed ID: 29162604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia.
    Shrestha P; van de Sluis B; Dullaart RPF; van den Born J
    Cell Signal; 2019 Mar; 55():53-64. PubMed ID: 30550765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria converts hepatic heparan sulfate to an effective proprotein convertase subtilisin kexin type 9 enzyme binding partner.
    Shrestha P; Yazdani S; Vivès RR; El Masri R; Dam W; van de Sluis B; van den Born J
    Kidney Int; 2021 Jun; 99(6):1369-1381. PubMed ID: 33609572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.
    Hadigal S; Koganti R; Yadavalli T; Agelidis A; Suryawanshi R; Shukla D
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31827001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease.
    Yilmaz Y; Eren F; Colak Y; Senates E; Celikel CA; Imeryuz N
    Scand J Gastroenterol; 2012 Dec; 47(12):1488-93. PubMed ID: 23137022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfate.
    Bishop JR; Foley E; Lawrence R; Esko JD
    J Biol Chem; 2010 May; 285(19):14658-62. PubMed ID: 20236939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation.
    Celie JW; Katta KK; Adepu S; Melenhorst WB; Reijmers RM; Slot EM; Beelen RH; Spaargaren M; Ploeg RJ; Navis G; van der Heide JJ; van Dijk MC; van Goor H; van den Born J
    Kidney Int; 2012 Apr; 81(7):651-61. PubMed ID: 22237752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of heparan sulfate proteoglycan on the cultured renal epithelial cells during oxalate exposure.
    Matsuo M
    Kurume Med J; 2008; 55(1-2):19-28. PubMed ID: 18981681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
    Yang Y; Macleod V; Miao HQ; Theus A; Zhan F; Shaughnessy JD; Sawyer J; Li JP; Zcharia E; Vlodavsky I; Sanderson RD
    J Biol Chem; 2007 May; 282(18):13326-33. PubMed ID: 17347152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.
    Wang A; Miralem T; Templeton DM
    Metabolism; 1999 Oct; 48(10):1220-9. PubMed ID: 10535382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14.
    Regős E; Abdelfattah HH; Reszegi A; Szilák L; Werling K; Szabó G; Kiss A; Schaff Z; Kovalszky I; Baghy K
    Matrix Biol; 2018 Aug; 68-69():474-489. PubMed ID: 29454902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase regulates levels of syndecan-1 in the nucleus.
    Chen L; Sanderson RD
    PLoS One; 2009; 4(3):e4947. PubMed ID: 19305494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
    Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
    Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of heparan sulfate proteoglycan (syndecan-1) on the renal epithelial cells during calcium oxalate monohydrate crystal attachment.
    Chikama S; Iida S; Inoue M; Kawagoe N; Tomiyasu K; Matsuoka K; Noda S; Takazono I
    Kurume Med J; 2002; 49(4):201-10. PubMed ID: 12652971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis.
    Shrestha P; Katta K; Talsma D; Naggi A; Hillebrands JL; van de Sluis B; van den Born J
    Front Cell Dev Biol; 2022; 10():798088. PubMed ID: 35345850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.